---
layout: splash
permalink: /
title: "Marc Machaalani, MD"
header:
  overlay_color: "#000" # Optional: Makes the top banner dark/professional
  overlay_filter: "0.5" # Optional: Darkens image if you add one later
excerpt: "Postdoctoral Fellow at Dana-Farber Cancer Institute."
feature_row:
  - image_path: #/assets/images/research-icon.png # You can add icons later, or remove this line
    title: "Research Focus"
    excerpt: "Integrative analyses of circulating and tumor biomarkers in renal cell carcinoma."
    url: "/research/"
    btn_label: "View Research"
    btn_class: "btn--primary"
  - image_path: #/assets/images/pub-icon.png # You can add icons later, or remove this line
    title: "Publications"
    excerpt: "High-impact publications in *Nature Medicine*, *JCO*, and more."
    url: "/publications/"
    btn_label: "Publication List"
    btn_class: "btn--primary"
---

Marc Machaalani, MD, is a postdoctoral research fellow at Dana-Farber Cancer Institute and Harvard Medical School, mentored by [Dr. Toni K. Choueiri](https://labs.dana-farber.org/choueirilab/). He received his medical degree from the Lebanese University in 2023.

His research focuses on integrative analyses of **circulating and tumor biomarkers in renal cell carcinoma**, with a specific emphasis on:
*   Host immunity and immune evasion
*   Gut dysbiosis and microbiome
*   Tumor genomics and metabolism

Dr. Machaalani has authored multiple high-impact publications in leading journals including *Nature Medicine*, *Nature Communications*, *Journal of Clinical Oncology*, and *European Urology*. He has presented his findings at major international meetings including ASCO, ESMO, and SITC.

He is the recipient of several national and international honors, including multiple ASCO Conquer Cancer and ESMO Merit Awards.

{% include feature_row %}